A translational view of airway epithelial dysfunction in COPD.

Eur Respir Rev · 2025 · PMC12709363 · PMID 41407389

Europe PMC DOI

hedged sentence

0.0061

closest p · 0.1× alpha

0.0061

boldest claim

The sentences

nominally significantp=0.0061actually significant

However, the study reported a nominally significant reduction in the rate of exacerbations (rate ratio 0.58, 95% CI 0.39–0.85; p=0.0061) and improved lung function among former smokers with itepekimab versus placebo [ 159 ].

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.